Drug safety issues raised in FDA official’s testimony
An FDA scientist raised questions about the safety of five marketed drugs while testifying Thursday on Capitol Hill, but his ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.